These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23335037)

  • 1. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch.
    Shaw AD; Kellum JA
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):497-503. PubMed ID: 23335037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients.
    Leberle R; Ernstberger A; Loibl M; Merkl J; Bunz M; Creutzenberg M; Trabold B
    Injury; 2015 Jan; 46(1):105-9. PubMed ID: 25240412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Starch solutions in Australia: the empire strikes back.
    Bellomo R
    Crit Care Resusc; 2013 Dec; 15(4):253-4. PubMed ID: 24289503
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute kidney injury after lung resection surgery: incidence and perioperative risk factors.
    Ishikawa S; Griesdale DE; Lohser J
    Anesth Analg; 2012 Jun; 114(6):1256-62. PubMed ID: 22451594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exclusion of suspect data raises question mark over safety of common plasma substitute.
    Mayor S
    BMJ; 2013 Feb; 346():f1132. PubMed ID: 23423548
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraoperative hydroxyethyl starch 70/0.5 is not related to acute kidney injury in surgical patients: retrospective cohort study.
    Endo A; Uchino S; Iwai K; Saito K; Sanui M; Takinami M; Uezono S
    Anesth Analg; 2012 Dec; 115(6):1309-14. PubMed ID: 23144442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk with strict glucose control and hydroxyethyl starch in severe sepsis. Routine intensive care treatments are now questioned].
    Berggren L
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3516-7. PubMed ID: 19133578
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of a balanced salt solution versus a 0.9% saline infusion for the prevention of contrast-induced acute kidney injury (BASIC trial): a study protocol for a randomized controlled trial.
    Jo HA; Park S; Kim CD; Jung HY; Cho JH; Cha RH; Kang EW; Chang TI; Kim S; Kim HJ; Chung BH; Lee JP; Park JT; Han SH; Yoo TH; Ryu DR; Moon SJ; Chang JH; Kim DK; Joo KW
    Trials; 2017 Oct; 18(1):461. PubMed ID: 28982378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
    Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
    Trials; 2015 Aug; 16():384. PubMed ID: 26314293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis.
    Gattas DJ; Dan A; Myburgh J; Billot L; Lo S; Finfer S;
    Anesth Analg; 2012 Jan; 114(1):159-69. PubMed ID: 22184610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In cardiac surgery patients does Voluven(R) impair coagulation less than other colloids?
    Raja SG; Akhtar S; Shahbaz Y; Masood A
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1022-7. PubMed ID: 21398650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials.
    Navickis RJ; Haynes GR; Wilkes MM
    J Thorac Cardiovasc Surg; 2012 Jul; 144(1):223-30. PubMed ID: 22578894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients.
    Martin C; Jacob M; Vicaut E; Guidet B; Van Aken H; Kurz A
    Anesthesiology; 2013 Feb; 118(2):387-94. PubMed ID: 23340352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of hydroxyethyl starch in resuscitation in the ICU.
    Myburgh J
    Crit Care Resusc; 2012 Dec; 14(4):251-2. PubMed ID: 23230872
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxyethyl starch 130/0.4: does "modern" mean safe?
    Wiedermann CJ
    Anesth Analg; 2009 Oct; 109(4):1346-7; author reply 1347. PubMed ID: 19762769
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hydroxyethyl starch for volume replacement therapy - a swan song?].
    Ittner KP
    Dtsch Med Wochenschr; 2013 Nov; 138(48):2450. PubMed ID: 24254341
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Boldt J
    Lancet; 2001 Aug; 358(9281):581-3. PubMed ID: 11526920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.